{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=GSK+Biologicals%27+Fluarix", "query": { "intervention": "GSK Biologicals' Fluarix" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 42, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=GSK+Biologicals%27+Fluarix&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T01:10:49.679Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00753272", "title": "Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "GSK Bio's influenza vaccine GSK2186877A", "type": "BIOLOGICAL" }, { "name": "Fluarix TM", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 43695, "start_date": "2008-09-15", "completion_date": "2011-01-05", "has_results": true, "last_update_posted_date": "2018-06-08", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 63, "location_summary": "Alabaster, Alabama • Huntsville, Alabama • Mobile, Alabama + 51 more", "locations": [ { "city": "Alabaster", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00753272" }, { "nct_id": "NCT01236040", "title": "Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "GSK Biologicals' investigational vaccine GSK2590066A", "type": "BIOLOGICAL" }, { "name": "GSK Biologicals' investigational vaccine GSK2592984A", "type": "BIOLOGICAL" }, { "name": "GSK Biologicals' investigational vaccine GSK2340274A", "type": "BIOLOGICAL" }, { "name": "GSK Biologicals' investigational vaccine GSK2340273A", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 521, "start_date": "2010-11-29", "completion_date": "2012-08-20", "has_results": false, "last_update_posted_date": "2017-05-10", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 4, "location_summary": "Anaheim, California • Stockbridge, Georgia • Lenexa, Kansas + 1 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Stockbridge", "state": "Georgia" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01236040" }, { "nct_id": "NCT01974895", "title": "Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "FluLaval® Quadrivalent", "type": "BIOLOGICAL" }, { "name": "Fluzone®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "35 Months", "sex": "ALL", "summary": "6 Months to 35 Months" }, "enrollment_count": 316, "start_date": "2013-10-23", "completion_date": "2014-07-03", "has_results": true, "last_update_posted_date": "2018-09-07", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 12, "location_summary": "Sacramento, California • West Covina, California • Altamonte Springs, Florida + 9 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "West Covina", "state": "California" }, { "city": "Altamonte Springs", "state": "Florida" }, { "city": "Fall River", "state": "Massachusetts" }, { "city": "Woburn", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01974895" }, { "nct_id": "NCT01000974", "title": "Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)", "type": "BIOLOGICAL" }, { "name": "ActHIB™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "Pediarix™", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "Rotarix™", "type": "BIOLOGICAL" }, { "name": "Engerix™-B", "type": "BIOLOGICAL" }, { "name": "Infanrix™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 4003, "start_date": "2010-06-18", "completion_date": "2013-07-17", "has_results": true, "last_update_posted_date": "2018-07-12", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 63, "location_summary": "Dothan, Alabama • Benton, Arkansas • Fayetteville, Arkansas + 59 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000974" }, { "nct_id": "NCT01310413", "title": "Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza", "Influenza Vaccines" ], "interventions": [ { "name": "Influenza A (H5N1) Virus monovalent vaccine", "type": "BIOLOGICAL" }, { "name": "Saline placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Months to 17 Years" }, "enrollment_count": 842, "start_date": "2011-03-07", "completion_date": "2014-01-26", "has_results": true, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 11, "location_summary": "Paramount, California • Sacramento, California • Newton, Kansas + 8 more", "locations": [ { "city": "Paramount", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Newton", "state": "Kansas" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Metairie", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01310413" }, { "nct_id": "NCT01949090", "title": "Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Investigational H7N1 vaccine GSK2789869A", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 363, "start_date": "2013-09-25", "completion_date": "2014-10-23", "has_results": true, "last_update_posted_date": "2017-11-17", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 5, "location_summary": "Hollywood, Florida • Meridian, Idaho • Lenexa, Kansas + 2 more", "locations": [ { "city": "Hollywood", "state": "Florida" }, { "city": "Meridian", "state": "Idaho" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT01949090" }, { "nct_id": "NCT03056924", "title": "Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Inflammatory Bowel Diseases" ], "interventions": [ { "name": "Pneumococcal Pneumonia vaccine", "type": "BIOLOGICAL" }, { "name": "Influenza vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Boston Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 173, "start_date": "2017-07-05", "completion_date": "2019-01-15", "has_results": false, "last_update_posted_date": "2019-12-30", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03056924" }, { "nct_id": "NCT01954251", "title": "Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults Aged 50 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Herpes Zoster" ], "interventions": [ { "name": "Herpes Zoster vaccine GSK 1437173A", "type": "BIOLOGICAL" }, { "name": "GSK Biologicals' quadrivalent seasonal influenza vaccine FLU-D-QIV GSK2321138A", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 829, "start_date": "2013-10-03", "completion_date": "2015-03-20", "has_results": true, "last_update_posted_date": "2018-05-02", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 3, "location_summary": "Phoenix, Arizona • Carnegie, Pennsylvania • Erie, Pennsylvania", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Carnegie", "state": "Pennsylvania" }, { "city": "Erie", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01954251" }, { "nct_id": "NCT01942265", "title": "H7N9 Mix and Match With AS03 and MF59 in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "AS03", "type": "DRUG" }, { "name": "MF59", "type": "DRUG" }, { "name": "Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "19 Years to 64 Years" }, "enrollment_count": 980, "start_date": "2013-09", "completion_date": "2015-01", "has_results": false, "last_update_posted_date": "2017-07-06", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 5, "location_summary": "Baltimore, Maryland • St Louis, Missouri • Nashville, Tennessee + 2 more", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01942265" }, { "nct_id": "NCT00197288", "title": "Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Influenza", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1847, "start_date": "2005-10", "completion_date": "2006-06", "has_results": false, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-09-27T01:10:49.679Z", "location_count": 15, "location_summary": "Clearwater, Florida • Evansville, Indiana • Baltimore, Maryland + 12 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Evansville", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00197288" } ] }